What glutathione is

Glutathione (GSH) is a tripeptide linking glutamic acid, cysteine and glycine, present widely inside human cells and one of the cell's most important small-molecule antioxidant and reducing systems. The critical structure is the thiol group (–SH) on the cysteine residue: it provides the reducing power and is also the source of every stability headache.

Two forms must be distinguished on the raw-material side: reduced glutathione (GSH) and oxidised glutathione (GSSG). Oxidising the thiol groups of two GSH molecules links them through a disulphide bond into one GSSG. Cosmetic formulas use the reduced GSH form, because it is the thiol that provides reducing power; GSSG's role in the body is to be recycled back to GSH by glutathione reductase. Always specify "reduced" in the purchasing spec and require a COA stating GSH content and the GSSG share, or you may well receive an already partly oxidised lot.

Commercial material is produced mainly by fermentation (engineered yeast or E. coli), with enzymatic and chemical routes also available. Physico-chemically it is a white crystalline powder, freely soluble in water, reasonably stable as a solid but very easily oxidised in solution, and potentially sulphurous in odour. Those last two points define the entire technical difficulty: once it is in water, the oxidation clock starts. That is why it works better in powders, ampoules and freeze-dried formats, and fails most easily in large open aqueous packs.

Ingredient fact box

How it works, plainly

The brightening pathway becomes clear once split into three stages: the production end (tyrosinase-catalysed melanin synthesis), the transfer end (melanin moving into keratinocytes) and the already-formed end (dopaquinone intermediates and deposited pigment). Glutathione acts mainly at the already-formed end — the essential difference between it and other brightening actives.

• It reduces, it does not inhibit. Dopaquinone is a key intermediate in the melanin chain, and glutathione can reduce such oxidised intermediates back, so the chain does not continue to melanin. The literature also reports effects on tyrosinase activity state (the enzyme depends on copper ions, and GSH chelates metals). Think of it as reducing the material halfway down the line, not as switching off the factory.
• It shifts the type of melanin. Studies report that glutathione can shift melanin synthesis toward pheomelanin, the lighter pigment — one reason it appears in premium brightening lines. An important caveat: this finding comes mainly from cell and in-vitro work, and the adequacy of human evidence remains debated, so no efficacy promise may be built on it.
• It is also an antioxidant. As the cell's principal reducing small molecule, it helps clear reactive oxygen species and maintain redox balance — which is why it is so often seen alongside vitamins C and E; both can help maintain GSH in its reduced state within a system.
• An honest note on evidence strength. Glutathione shows pigmentation-related results in cell work and some human studies, but high-quality, large, eye-area-specific randomised human trials are limited, and route, vehicle, concentration and assessment methods vary widely. Verify on PubMed with "glutathione", "skin pigmentation" and "melanin". Claims should read "helps reduce the look of under-eye darkness and uneven tone" — never "whitens", "removes spots" or "treats pigmentation".

A blunt note for sourcing: glutathione does not work as a solo brightening active carrying the whole claim — it oxidises, costs money and is hard to keep odour-free, so using it alone often means spending the budget without retaining the activity. A more practical route is to place it inside a combined system of "inhibit production + block transfer + reduce what is already formed", where it carries one stage, and to confirm the target market's position on its use with a regulatory adviser at kick-off.

Best-fitting formats

Use level and formulation notes (verify by bench trial)

Common reference level: a common reference range in cosmetics is ≈0.1%–2%, with the practical ceiling governed by three things: target-market rules, the odour threshold and shelf-life GSH retention. The actual level is set on the bench by format, target market and stability data, converted against the GSH content and GSSG share on the supplier COA — with a partly oxidised lot, dosing on total labelled amount directly produces under-strength product.

• pH comes first. Hold it at 5.0–6.5, a mildly acidic window. The thiol is more stable under mildly acidic conditions, while alkaline conditions markedly accelerate oxidation to GSSG; verify separately if alkaline ingredients must be present.
• Oxygen and metal ions are the two accelerators. Recommended: deoxygenate or control oxygen in process water, reduce headspace oxygen during blending and filling, and control copper and iron residues (equipment, water, pigments); add a chelator such as disodium EDTA where needed, checking its status in the target market.
• Design the antioxidant system as a whole. Pair with vitamin C or its derivatives and vitamin E to help hold GSH in the reduced state, while avoiding long-term coexistence with strong oxidisers and peroxide-based systems.
• Validate the sulphurous odour up front. Odour is the most common consumer complaint with this ingredient. Run sensory evaluation plus headspace or odour description during sampling and repeat it under 40 °C acceleration; resolve through fragrance masking, a lower level or a different raw-material lot as needed.
• Addition order and temperature. Fold into the water phase as a pre-dissolved stock solution at low temperature (below 40 °C), avoiding prolonged or repeated heating.
• Packaging decides the outcome. Prefer individually foiled single sheets, ampoules, airless pumps or small light-protective units; be cautious with wide-mouth jars and repeatedly opened multi-dose bottles, and state the period after opening on the label.
• Put the raw-material spec into the purchase order. State reduced form (GSH), assay (commonly ≥98%), maximum GSSG share, heavy-metal and microbial limits, and the identification method (HPLC), and require a COA plus stability data.
• Stability protocol. 40 °C for 3 months plus freeze–thaw and light exposure, with both GSH retention and GSSG formation measured and odour change recorded. Appearance and pH alone are not enough for release.

The figures above are common reference levels for eye care formulas; the actual use level is set by the formulation engineer based on dosage form, compatibility and target-market rules. Permitted use conditions, limits and labelling requirements differ by market — complete a compliance review for each destination before shipment. All descriptions here are general cosmetic applications and appearance or skin-feel statements, not medical advice or efficacy guarantees.

Compliance and market notes (verify per target market)

• China: first verify listing status and historical maximum use level in the Inventory of Existing Cosmetic Ingredients in China (2021 edition) (per the latest NMPA announcement), then complete filing under the Cosmetic Supervision and Administration Regulation. Note especially that "freckle-removing and whitening" cosmetics are special cosmetics in China, requiring registration and human efficacy substantiation under the efficacy-claim evaluation rules, with a markedly longer timeline and higher cost than ordinary cosmetics. Confirm this path before the project is approved. Also note that glutathione has drug or food-supplement uses in some markets, which must be strictly separated from cosmetic use.
• EU (EC) No 1223/2009: declare the ingredient and impurity profile accurately in the CPNP notification, PIF and CPSR and complete the safety assessment; claims must meet the (EU) No 655/2013 common criteria. Assessments from the food or drug domain cannot be carried over to cosmetic use — argue the cosmetic route on its own.
• US MoCRA (2022): facility registration, product listing, safety substantiation, adverse-event reporting and record-keeping apply, with labelling under the FD&C Act and relevant 21 CFR provisions. Cosmetic ingredients and finished products generally do not undergo pre-market approval — never write "FDA approved".
• Japan / Korea: glutathione carries boundary questions between medicinal and cosmetic use in both markets (injectable use, for example, is regulated as a drug). Listing status, limits, claim boundaries and label format differ under each cosmetic route, so verify market by market before export rather than carrying over China or EU experience.
• Claim red lines (all markets): never promise with "whitening", "spot removal", "treats pigmentation", "eliminates melanin", "medical" or "detox". On the Chinese site use appearance wording such as "helps improve the look of periorbital dullness and uneven tone". Never imply any link between medical uses (injection, oral, infusion) and topical cosmetic use.
• Recommended action: at project kick-off, give your regulatory adviser four items — ingredient, use level, dosage form and claim copy — for one upfront review. Because this ingredient crosses use-category boundaries, obtain written confirmation market by market before moving to production.

Ingredient pairings

• Glutathione + vitamin C / ethyl ascorbic acid (1%–3%): the classic redox pair in brightening. A vitamin C system helps hold GSH in its reduced state, and together they cover the already-formed end; note that vitamin C carries its own pH and stability requirements, to be verified together.
• Glutathione + alpha-arbutin (0.5%–2%) + niacinamide (2%–5%): a three-pathway division of labour — reduce what is formed, inhibit production, block transfer — the common skeleton of premium even-tone lines; all three are hydrophilic and compatible in aqueous systems.
• Glutathione + vitamin E (0.5%–2%): a water-plus-oil antioxidant network that also slows oxidation of the system, indirectly protecting GSH.
• Glutathione + ergothioneine (0.05%–0.5%): two sulphur-containing antioxidant systems covering different redox tiers, suited to a combined "antioxidant + brightening" positioning; run metal-ion control and odour verification together.
• Glutathione + sodium hyaluronate (0.1%–0.5%) + panthenol (1%–3%): a hydrating, soothing base that improves periorbital tolerance — good for gentle daily brightening lines.
• Use with care: avoid long-term coexistence with strong oxidisers and peroxide-based systems; control copper and iron strictly (they catalyse thiol oxidation); verify before combining with alkaline ingredients or high-pH systems; bottling with metal-ion actives such as copper peptides requires both compatibility and GSH-retention verification; avoid prolonged high-temperature processing.

Formulation pairing cards

FAQ

Image briefs